Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Albireo Pharma, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 109
- +13 vs. Q4 2021
- Shares held
- 16.6M
- +1.04M (+6.7%) vs. Q4 2021
- Total value
- $495.4M
- +$132.9M (+36.7%) vs. Q4 2021
- New holders
- 21
- 30 more added
- Sold out
- 8
- 39 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALBO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $44 |
| Q1 2026 | 1 | $44 |
| Q4 2025 | 1 | $44 |
| Q3 2025 | 1 | $744 |
| Q2 2025 | 1 | $744 |
| Q1 2025 | 1 | $744 |
| Q4 2024 | 1 | $744 |
| Q3 2024 | 1 | $744 |
| Q2 2024 | 1 | $744 |
| Q1 2024 | 1 | $744 |
| Q4 2023 | 1 | $744 |
| Q3 2023 | 1 | $744 |
| Q2 2023 | 1 | $756 |
| Q1 2023 | 3 | $2.04M |
| Q4 2022 | 96 | $401.7M |
| Q3 2022 | 109 | $372.0M |
| Q2 2022 | 103 | $352.6M |
| Q1 2022 | 109 | $495.4M |
| Q4 2021 | 96 | $362.5M |
| Q3 2021 | 94 | $477.0M |
| Q2 2021 | 99 | $546.1M |
| Q1 2021 | 100 | $589.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Albireo Pharma, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prosight Management, LP | 480,000 | $14.3M | 10.08% | −34,082−6.6% | Reduced |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15.5M | 4.74% | +518,342 | New |
| ArrowMark Colorado Holdings LLC | 640,893 | $19.1M | 0.17% | +4,547+0.7% | Added |
| State Street Corp | 908,728 | $27.1M | 0.00% | −84,104−8.5% | Reduced |
| Vanguard Group Inc | 977,665 | $29.2M | 0.00% | +42,235+4.5% | Added |
| Chicago Capital, LLC | 1,011,744 | $30.2M | 1.30% | +162,505+19.1% | Added |
| BlackRock Inc. | 1,151,032 | $34.3M | 0.00% | −17,751−1.5% | Reduced |
| Federated Hermes, Inc. | 2,358,624 | $70.4M | 0.16% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 2,360,139 | $70.4M | 1.46% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −129,126−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −104,521−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −22,889−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −20,782−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,547−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −8,961−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,125−100.0% | Sold out |